SHILPA MEDICARE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 518.6 INR | +2.26% |
|
+3.20% | +57.02% |
| Apr. 18 | Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US | MT |
| Apr. 17 | Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 588B | ||||||
| 364B | ||||||
| 326B | ||||||
| 285B | ||||||
| 239B |
